Guideline

Guidelines: updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring

Year of Publication

2021

Issuing Institution

WHO

Links

WHO IRIS,WHO IRIS,Google Scholar

Recommendations

7 included recommendations

The dapivirine vaginal ring may be offered as an additional prevention choice for women at substantial risk of HIV infection as part of combination prevention approaches

Status

Maintained

Recommended in favor

Conditional

Certainty of evidence

Moderate

Point-of-care nucleic acid testing should be used to diagnose HIV among infants and children younger than 18 months of age.

Status

Updated

Recommended in favor

Strong

Certainty of evidence

High

Point-of-care viral load may be used to monitor treatment among people living with HIV receiving ART

Status

Maintained

Recommended in favor

Conditional

Certainty of evidence

Moderate

Treatment monitoring; People living with HIV who are initiating or receiving ART: Revised treatment monitoring algorithm

Status

Updated

(Adults and adolescents) ART should be started as soon as possible within two weeks of initiating TB treatment, regardless of CD4 count, among people living with HIV

Status

Maintained

Recommended in favor

Strong

Certainty of evidence

Low

(Children and infants) ART should be started as soon as possible within two weeks of initiating TB treatment, regardless of CD4 count, among people living with HIV

Status

Maintained

Recommended in favor

Strong

Certainty of evidence

Very low

Among people living with HIV with signs and symptoms suggesting TB, except for central nervous system disease (meningitis), initiate ART while rapidly investigating for TB, with close follow-up within seven days to initiate TB treatment if TB is confirmed.

Status

Updated